Patents

US 11987794 B2: Products and compositions

Granted
2024-05-21
Filed
2022-03-07 application 17688789
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with target gene expression or inhibit target gene expression and therapeutic uses of such products.

Source: PVGPATDIS, file of 2026-04-10 (ipg240521.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Sapience Therapeutics, Inc. 48 patentsUS company or organizationBerlin, DESAPIENCE THERAPEUTICS, INC. State business registration EXACT high confidence: identical full name and state
Sapience Therapeutics, Inc. Form D issuer EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Judith HauptmannBerlin, DE10PVGPATDIS, file of 2026-04-10
Dmitry SamarskyBerlin, DE30PVGPATDIS, file of 2026-04-10
Adrien WeingärtnerBerlin, DE9PVGPATDIS, file of 2026-04-10
Lucas BethgeBerlin, DE12PVGPATDIS, file of 2026-04-10
Christian FrauendorfBerlin, DE12PVGPATDIS, file of 2026-04-10
Alison GALLAFENTBerlin, DE2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/113PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-06-13Assignment
Assignment of assignor's interest
BETHGE, LUCAS signed 2019-09-20
FRAUENDORF, CHRISTIAN signed 2019-09-20
HAUPTMANN, JUDITH signed 2019-09-20
SAMARSKY, DMITRY signed 2019-09-20
WEINGÄRTNER, ADRIEN signed 2019-09-20
GALLAFENT, ALISON signed 2019-10-22
SILENCE THERAPEUTICS GMBH BERLIN60184/308ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.